Recursion Pharmaceuticals Inc (NASDAQ: RXRX) kicked off on Monday, up 2.34% from the previous trading day, before settling in for the closing price of $4.71. Over the past 52 weeks, RXRX has traded in a range of $3.79-$12.36.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -35.28%. While this was happening, its average annual earnings per share was recorded 7.54%. With a float of $414.67 million, this company’s outstanding shares have now reached $485.21 million.
Recursion Pharmaceuticals Inc (RXRX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Recursion Pharmaceuticals Inc is 20.38%, while institutional ownership is 48.79%. The most recent insider transaction that took place on Dec 04 ’25, was worth 185,200. In this transaction Chief Executive Officer of this company sold 40,000 shares at a rate of $4.63, taking the stock ownership to the 933,839 shares. Before that another transaction happened on Dec 02 ’25, when Company’s Director sold 220,000 for $4.37, making the entire transaction worth $961,400. This insider now owns 6,869,863 shares in total.
Recursion Pharmaceuticals Inc (RXRX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.53 earnings per share (EPS), lower than consensus estimate (set at -0.42) by -0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.13% during the next five years compared to -35.28% drop over the previous five years of trading.
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Trading Performance Indicators
Take a look at Recursion Pharmaceuticals Inc’s (RXRX) current performance indicators. Last quarter, stock had a quick ratio of 4.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 57.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.81, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.23 in one year’s time.
Technical Analysis of Recursion Pharmaceuticals Inc (RXRX)
The latest stats from [Recursion Pharmaceuticals Inc, RXRX] show that its last 5-days average volume of 21.88 million was inferior to 29.35 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 79.86%.
During the past 100 days, Recursion Pharmaceuticals Inc’s (RXRX) raw stochastic average was set at 29.97%, which indicates a significant decrease from 78.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.29 in the past 14 days, which was lower than the 0.38 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.14, while its 200-day Moving Average is $5.30. Now, the first resistance to watch is $5.05. This is followed by the second major resistance level at $5.27. The third major resistance level sits at $5.46. If the price goes on to break the first support level at $4.64, it is likely to go to the next support level at $4.45. The third support level lies at $4.23 if the price breaches the second support level.
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Key Stats
The company with the Market Capitalisation of 2.51 billion has total of 519,838K Shares Outstanding. Its annual sales at the moment are 58,840 K in contrast with the sum of -463,660 K annual income. Company’s last quarter sales were recorded 5,180 K and last quarter income was -162,250 K.
